XLone-Puro Cas13d P2A eGFP-NLS
(Plasmid
#155182)
-
PurposePiggybacTransposon-based tunable and temporal expression control of Cas13d and nuclear eGFP
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 155182 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAddgene #154399
- Backbone size w/o insert (bp) 6614
- Total vector size (bp) 9512
-
Vector typeMammalian Expression, Unspecified ; Piggybac transposon
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCasRx
-
Alt nameCas13d
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2898
- Promoter TRE3G
-
Tags
/ Fusion Proteins
- NLS (C terminal on insert)
- P2A eGFP NLS (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site NheI, SpeI (not destroyed)
- 5′ sequencing primer gcgcctataaaagagtgctga
- 3′ sequencing primer M13 FWD (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byThe Cas13d sequence was PCR amplified from pLentiRNACRISPR_005 - hU6-DR_BsmBI-EFS-RfxCas13d-NLS-2A-Puro-WPRE, a gift from Neville Sanjana (Addgene #138147)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
XLone-Puro Cas13d P2A eGFP-NLS was a gift from Xiaoping Bao (Addgene plasmid # 155182 ; http://n2t.net/addgene:155182 ; RRID:Addgene_155182) -
For your References section:
Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells. Chang Y, Syahirah R, Oprescu SN, Wang X, Jung J, Cooper SH, Torregrosa-Allen S, Elzey BD, Hsu AY, Randolph LN, Sun Y, Kuang S, Broxmeyer HE, Deng Q, Lian X, Bao X. Biomaterials. 2022 May 6;285:121569. doi: 10.1016/j.biomaterials.2022.121569. 10.1016/j.biomaterials.2022.121569 PubMed 35567999